Heechul K. Nam

Seoul St. Mary's Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

Journal: Radiology

Published: August 04, 2026

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

Journal: Clinical and molecular hepatology

Published: May 09, 2026

Neutrophil-to-Lymphocyte Ratio and Extrahepatic Spread Predict Response and Survival in Unresectable Hepatocellular Carcinoma.

Neutrophil-to-Lymphocyte Ratio and Extrahepatic Spread Predict Response and Survival in Unresectable Hepatocellular Carcinoma.

Journal: Cancer research and treatment

Published: May 08, 2026

Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure.

Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure.

Journal: Targeted oncology

Published: April 18, 2026

Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance?

Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance?

Journal: Alimentary pharmacology & therapeutics

Published: February 20, 2026

Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy.

Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy.

Journal: NPJ digital medicine

Published: October 25, 2025

Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments.

Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments.

Journal: Liver cancer

Published: September 10, 2025

Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.

Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.

Journal: Journal of viral hepatitis

Published: September 09, 2025

Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

Journal: Hepatology (Baltimore, Md.)

Published: September 05, 2025

Reply: The CRAPT-M score: Robust enough for clinical practice?

Reply: The CRAPT-M score: Robust enough for clinical practice?

Journal: Hepatology (Baltimore, Md.)

Published: July 30, 2025

The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study.

The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study.

Journal: Journal of gastroenterology

Published: June 27, 2025

Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.

Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.

Journal: Hepatology (Baltimore, Md.)

Published: March 04, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026